'Digital Health' Humanscape Raises 20 Billion KRW in Series C Funding

Shinhan Asset Management, Kyobo, Hana Securities Participate in Investment
Targeting Southeast Asian Markets Including Indonesia and Vietnam

Digital health startup Humanscape has completed a 20 billion KRW investment round and is set to aggressively target the global healthcare market.

On the 12th, Humanscape announced that it had secured a Series C investment worth 20 billion KRW. With this funding, Humanscape's total accumulated investment has increased to 55 billion KRW.

New investors include Shinhan Bank, Shinhan Asset Management, Kyobo Securities, Hana Securities, and Mint Venture Partners. Existing investors such as GC Green Cross Holdings, CareLabs, and UTC Investment also contributed additional funds.

A Humanscape representative explained, "Despite growing uncertainties in the venture investment market since the second half of last year, we successfully closed the funding round. Our growth strategy to enter the global market based on a proven business model in Korea has drawn positive responses from investors."

Humanscape plans to accelerate its global market expansion and profitability. In Indonesia, its first overseas market, the company began monetizing its pregnancy and childcare platform 'Mamitok' in February this year. From the early stages, about 20-30% of new users have been using the Mamitok solution through paid subscriptions, showing a smooth trend.

In the Vietnamese market, Humanscape is actively securing partner hospitals. Considering the dominance of public hospitals in childbirth in Vietnam, Humanscape has established strategic partnerships with the General Office for Population and Family Planning (GOPFP) under the Vietnamese Ministry of Health and the Vietnam Medical Association (VMA) to build a solid business foundation.

Humanscape is also accelerating the market expansion of its observational research clinical data management solution, 'RareData.' Launched in October last year, RareData targets the rare disease observational research sector, where clinical data is fragmented and difficult to manage due to the high cost of existing solutions. The company is expanding the distribution of this solution to tertiary hospitals and affiliated research teams.

Jang Min-hoo, CEO of Humanscape, stated, "Based on the funds raised in this investment round, we will further strengthen our global market penetration and accelerate full-scale revenue generation. We aim to secure the largest global user base in the digital healthcare sector."